MC (Moelis) ROCE % : 80.36% (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Moelis ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Moelis's annualized ROCE % for the quarter that ended in Dec. 2024 was 80.36%.

Moelis ROCE % Historical Data

The historical data trend for Moelis's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moelis ROCE % Chart

Moelis Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

43.12

75.64

32.70

-6.56

27.01

Moelis Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-6.36	3.92	13.40	10.37	80.36

Moelis ROCE % Calculation

Moelis's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	172.945	/	( ( (1179.759 - 601.613)	+	(1378.936 - 676.318) )	/ 2 )
	=	172.945	/	( (578.146	+	702.618)	/ 2 )
	=	172.945	/	640.382
	=	27.01 %

Moelis's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	526.044	/	( ( (1153.062 - 546.535)	+	(1378.936 - 676.318) )	/ 2 )
	=	526.044	/	( ( 606.527	+	702.618 )	/ 2 )
	=	526.044	/	654.5725
	=	80.36 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Moelis (NYSE:MC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Moelis ROCE % Related Terms

Thank you for viewing the detailed overview of Moelis's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Moelis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Moelis & Co (NYSE:MC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

399 Park Avenue, 4th Floor, New York, NY, USA, 10022

Website

https://www.moelis.com

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Executives

Christopher Callesano	officer: SVP & Principal Acct Officer	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Kenneth Moelis	director, 10 percent owner, officer: Chairman and CEO	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Kenneth Shropshire	director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10011
Ciafone Katherine Pilcher	officer: Chief Operating Officer	399 PARK AVE, NEW YORK NY 10022
Joseph Simon	officer: Chief Financial Officer	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Navid Mahmoodzadegan	director, officer: Managing Director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Jeffrey Raich	director, officer: Managing Director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Osamu R. Watanabe	officer: General Counsel and Secretary	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Eric Cantor	director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Elizabeth Crain	officer: Chief Operating Officer	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Laila Worrell	director	399 PARK AVENUE, NEW YORK NY 10022
Yolonda C Richardson	director	399 PARK AVENUE, NEW YORK NY 10022
Leaman J Richard Iii	director, officer: Managing Partner	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
John A Allison	director	PO BOX 1250, WINSTON SALEM NC 27102-1250
Yvonne Greenstreet	director	PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, PARSIPPANY NJ 07054